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Summary
Both conventional T (Tconv) cells and regulatory T (Treg) cells are activated through ligation of 
the T cell receptor (TCR) complex, leading to the induction of the transcription factor NF- ?B. In 
Tconv cells, NF- ?B regulates expression of genes essential for T cell activation, proliferation and 
function. However the role of NF- ?B in Treg function remains unclear. We conditionally deleted 
canonical NF- ?B members p65 and c-Rel in developing and mature Treg cells and found they 
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have unique but partially redundant roles. c-Rel was critical for thymic Treg development while 
p65 was essential for mature Treg identity and maintenance of immune tolerance. Transcriptome 
and NF- ?B p65 binding analyses demonstrated a lineage specific, NF- ?B-dependent 
transcriptional program, enabled by enhanced chromatin accessibility. These dual roles of 
canonical NF- ?B in Tconv and Treg cells highlight the functional plasticity of the NF- ?B 
signaling pathway and underscores the need for more selective strategies to therapeutically target 
NF- ?B.
Graphical abstract
INTRODUCTION
Homeostasis of the immune system is maintained by a delicate balance between activation 
and suppression. Disruption of this balance can lead to autoimmune diseases and immune 
dysfunction. Immune tolerance is maintained through central and peripheral mechanisms, 
including specialized cell subsets. Amongst these, CD4+FoxP3+ regulatory T cells (Treg 
cells) play a pivotal role in the inhibition of immune responses. Treg cells, which develop in 
the thymus or in the periphery, are characterized by the expression of the transcription factor 
FoxP3, and by their ability to suppress the activation and function of conventional T cells 
(Tconv), and other immune cells, to maintain immune homeostasis. Thus, although they 
arise from the same progenitors in the thymus, Tconv and Treg cells have completely 
opposed biological roles. Remarkably, it is still unclear how engagement of the same T cell 
receptor on these two related cell types induces such different biological outcomes, despite 
the fact that many of the same signaling molecules and transcription factors are activated 
(Levine et al., 2014).
The NF- ?B transcription factor family consists of five members, p65 (RelA), c-Rel (encoded 
by Rela and Rel, respectively), p105/p50, p100/p52 and RelB. NF- ?B is activated in 
response to a variety of signals through two distinct pathways that are known as the 
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canonical and noncanonical pathways. The canonical pathway leads to activation of NF- ?B 
heterodimers containing primarily p65 or c-Rel, bound to p50, whereas the noncanonical 
pathway leads to activation of NF- ?B heterodimers consisting of RelB and p52. Stimulation 
of the TCR together with costimulation of CD28 leads to activation of canonical NF- ?B 
complexes, which translocate to the nucleus, where they bind to specific sites in promoters 
and enhancers of target genes. Thus, in Tconv cells, NF- ?B induces expression of genes 
responsible for T cell activation, proliferation and production of inflammatory cytokines. 
Given the well-documented role for NF- ?B in activation of a variety of immune effector 
cells, it was unclear what role NF- ?B might play in Treg cells, whose biological function is 
to suppress the immune response.
We, along with other groups, have shown previously that NF- ?B c-Rel plays an essential 
role in the thymic development of Treg cells (Isomura et al., 2009; Long et al., 2009; Ruan 
et al., 2009). In Treg precursors, c-Rel binds directly to the CNS3 enhancer region and 
promotes the expression of FoxP3. Treg development is impaired in mice lacking c-Rel and 
hence the role of NF- ?B in Treg function has remained unexplored. To determine how NF-
 ?B contributes to mature Treg function we have now conditionally deleted floxed alleles of 
NF- ?B Rela and Rel in Tregs. We found that both c-Rel and p65 played important, but only 
partly redundant roles in Treg function, and only deletion of both c-Rel and p65 led to 
completely non-functional Tregs and lethal autoimmunity, similar to that seen in mice 
lacking Tregs. Analysis of the gene expression program in these cells revealed that 
expression of several key genes that are known to be critical for Treg identity and function 
was NF- ?B-dependent. This suggested that NF- ?B was able to access different target genes 
in Treg and Tconv cells. Genome-wide p65 ChIPseq revealed a large number of lineage 
specific target genes in Treg cells, associated with an enhanced open chromatin 
conformation in Tregs. Therefore, our results suggested that an altered global chromatin 
state in Tregs allows NF- ?B induced by the TCR to access lineage-specific binding sites and 
establish Treg identity and suppressive function. In summary, the studies presented here 
reveal the plasticity of a key transcription factor in regulating the diametrically opposed 
biological functions of two highly related cell types.
RESULTS
Canonical NF- ?B signaling is crucial for Treg development
We explored the specific roles of the canonical NF- ?B subunits c-Rel and p65 in natural 
(n)Treg and induced (i)Treg development by crossing mice with floxed Rel and Rela alleles 
with a Cd4cre deleter strain resulting in loss of p65 and c-Rel expression (Figure S1A). We 
did not observe changes in development of CD4+ and CD8+ T cells in the thymus (data not 
shown). However, we observed a dramatic decrease in the proportion and number of 
CD4+CD8−FoxP3−CD25+GITR+ Treg precursors in mice lacking p65 and c-Rel (Figure 1A, 
B and S1B, C). There was a graded reduction in the frequency and number of FoxP3+ Treg 
cells upon deletion of Rel, Rela, or both. This demonstrated unique and partially redundant 
functions of both canonical NF- ?B subunits in the development of Treg progenitors.
To assess whether NF- ?B activation was required for the transition of Treg progenitors to 
FoxP3+ Treg cells, we isolated Treg progenitors and induced deletion of NF- ?B subunits in 
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vitro using TAT-CRE protein (Joshi et al., 2002; Lio and Hsieh, 2008). We observed a 3-fold 
reduction in Treg frequency in cells lacking Rel, or both Rela and Rel (Figure 1C and data 
not shown). Hence these results suggested an intrinsic, specific and non-redundant role for 
canonical NF- ?B subunits in the specification of FoxP3− Treg precursors and in the 
expression of FoxP3. Moreover, deletion of Rela alone led to a modest, but statistically 
significant, decrease in the proportion and numbers of Treg cells in both spleen and lymph 
nodes (LN), but not in other tissues (Figure 1D–F and S1D). Mice lacking Rel exhibited a 
dramatic decrease in Tregs frequency in all tissues. This was further amplified by the 
deletion of both p65 and c-Rel, demonstrating a partially redundant role of both NF- ?B 
subunits in homeostasis of peripheral Treg cells. Finally, we assessed the potential role of 
each NF- ?B subunit in iTreg induction in vitro. Upon stimulation with Interleukin 2 (IL-2) 
and Transforming Growth Factor-Beta (TGF- ?), cells lacking Rela gave rise to normal 
proportions of FoxP3+ cells (Figure 1G). Naïve T cells lacking Rel exhibited a partial defect 
in iTreg induction that was rescued by increasing doses of TGF ?. However, full ablation of 
the NF- ?B canonical pathway, by deletion of both Rela and Rel, almost completely 
abolished the in vitro differentiation of naïve T cells into iTreg cells. These results suggested 
that, although p65 and c-Rel partially compensated for one another, they also played discrete 
roles in multiple steps of both nTreg and iTreg development.
Treg-specific deletion of c-Rel leads to a late and mild inflammatory phenotype
To bypass the block imposed by loss of NF- ?B on Treg development and assess the role of 
NF- ?B subunits in the homeostasis and function of mature Treg cells, we deleted Rel in 
Tregs, but not Tconv cells, using the Foxp3YFP-cre deleter strain (Figure S2A). We did not 
observe early lethality or systemic inflammation (Figure 2A and data not shown) in 
Foxp3YFP-creRelf/f mice. Although 6–8 week-old Foxp3YFP-creRelf/f mice did not show any 
overt signs of illness, lung and liver histology revealed a modest increase in lymphocyte 
infiltration relative to the WT controls (Figure 2B). Moreover, the cellularity of the 
peripheral LN, but not the spleen, was significantly increased (Figure 2C). The percentage 
and number of activated CD4+ and CD8+ T cells were similar between WT and 
Foxp3YFP-creRelf/f mice in spleen (Figure 2D–F), but there was a mild increase in CD8+ T 
cell activation in LN (Figure S2B). We observed a trend toward increased production of 
IL-17 and Interferon (IFN)- by splenic CD4+ T cells in Foxp3YFP-creRelf/f mice (Figure 2G, 
H). Also, production of IFN ?, but not IL-17, by CD4+ T cells in the colon lamina propria 
and skin was increased in Rel-deficient mice (Figure S2E, F). The proportion and number of 
Treg cells were unaffected by the absence of c-Rel (Figure 2I, J and S2C). This data showed 
that c-Rel in Tregs was mostly dispensable for the maintenance of immune tolerance despite 
its crucial role in thymic Treg development.
Although aged Foxp3YFP-creRelf/f mice did not exhibit any obvious morbidity, 8-month old 
mutant mice showed overt splenomegaly and lymphadenopathy (data not shown), and liver 
and lung histology revealed increased lymphocytic infiltrates (Figure S2G). We also 
observed an increase in the frequency of effector T cells with a skewing towards IFN ?
secreting T helper 1 (Th1) cells in spleen and LN (Figure S2H). Finally, we tested the 
suppressive function of c-Rel deficient Treg in T cell transfer-induced colitis, in which naïve 
Tconv cells were transferred to Rag1−/− recipients alone or with WT or mutant Tregs. In 
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contrast with WT Tregs, Rel-deficient cells were completely unable to protect the recipient 
animals from weight loss or intestinal pathology (Figure 2K, L) suggesting a role for c-Rel 
in Treg suppressive function. Taken together, this data showed that c-Rel was largely 
dispensable for maintenance of immune tolerance but was important for regulation of Treg 
function in lymphopenic hosts.
Mice with Treg specific deletion of NF- ?B p65 develop a severe inflammatory phenotype
To assess the potential role of p65 in Tregs, we crossed Rela-floxed mice with Foxp3YFP-cre 
mice, which resulted in selective loss of p65 in Treg, but not Tconv cells (Figure S3A). 
Foxp3YFP-creRelaf/f mice were smaller than their WT littermates (data not shown) and 
showed accelerated mortality, with all mice dying between 5–15 weeks after birth (Figure 
3A). This was associated with lymphoproliferative disease including splenomegaly and 
lymphadenopathy, as well as lymphocytic infiltration of lung and liver (Figure 3B, C and 
data not shown). Dorsal skin sections from Foxp3YFP-cre Relaf/f mice revealed hyperplastic 
epidermis and a robust immune cell infiltration with significant epidermal thickening (Figure 
S3B, C). Moreover, there was a dramatic increase in frequencies and numbers of CD4+ and 
CD8+ T cells secreting IFN- ? and with an activated/memory phenotype (Figure 3D–H and 
S3D).
Despite the lymphoproliferative disease, the proportion and number of Treg cells were in 
fact increased in secondary lymphoid tissues (Figure 3I, J and S3E). p65-deficient Tregs 
displayed normal expression of CD25 and Helios, which are important factors for Treg 
homeostasis (Figure S3F). This suggested a defect in the suppressive function of Tregs 
lacking p65. Tregs from Foxp3YFP-creRelaf/f mice were able to suppress proliferation of 
Tconv cells in vitro (Figure S3G). However, Rela−/− Treg cells were completely unable to 
rescue recipient mice from colitis in an in vivo suppression assay (Figure 3K, L). This, 
together with the increased production of IFN ? and IL-17 by CD4+ T cells in multiple 
tissues of Foxp3YFP-creRelaf/f mice (Figure S3H, I), demonstrated that p65 is essential for 
Treg-dependent maintenance of immune tolerance.
Complete ablation of canonical NF- ?B in Tregs leads to a Scurfy-like phenotype
Our results (Figure 1) suggested that c-Rel and p65 exhibited partially redundant functions, 
and therefore to test this prediction we generated Foxp3YFP-creRelaf/fRelf/f mice (Figure 
S4A). Consistent with our hypothesis, these mice showed a profound Scurfy-like phenotype 
with robust cutaneous inflammation and severe runting (data not shown). 
Foxp3YFP-creRelaf/fRelf/f mice died between 2 and 4 weeks after birth (Figure 4A) and 
demonstrated pronounced lymphocytic infiltration in lungs and liver (Figure 4B), as well as 
severe splenomegaly and lymphadenopathy (Figure 4C). Foxp3YFP-creRelaf/fRelf/f mice had 
significantly higher numbers and frequencies of CD44high central and effector memory 
CD4+ and CD8+ T cells (Figure 4D–F and S4B)). There was also an increase in the number 
and frequency of CD4+ Tconv cells from mutant mice that produced IFN ?(Figure 4G, H). 
In addition, we also detected an increase in antibodies recognizing double stranded DNA 
(anti-dsDNA antibodies) in Foxp3YFP-creRelaf/fRelf/f mice (Figure S4E), similar to 
observations in Scurfy mice (Aschermann et al., 2013). Thus, canonical NF- ?B in Treg cells 
is required for cellular and humoral tolerance.
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This phenotype observed in Foxp3YFP-creRelaf/fRelf/f mice suggested a profound loss of 
Treg homeostasis. Foxp3YFP-creRelaf/fRelf/f mice had decreased Treg frequency in all 
examined tissues (Figure 4I, J and S4C). Also, the Mean Fluorescence Intensity (MFI) of 
Helios and CD25 was decreased in NF- ?B-deficient Treg cells (Figure S4D). We next 
investigated whether those Treg cells were functional in vivo. In contrast to WT cells, 
Rela−/−Rel−/− Tregs were completely unable to rescue Rag1−/− mice from colitis induced by 
transfer of WT CD4+ Tconv cells (Figure 4K, L). Increased production of inflammatory 
cytokines in multiple tissues also confirmed the inability of Rela-Rel-deficient Treg cells to 
suppress effector and systemic inflammatory responses (Figure S4F, G). Thus, complete 
ablation of canonical NF- ?B signaling impairs Treg homeostasis and function. This 
highlighted the crucial role of the canonical NF- ?B pathway in the maintenance of immune 
tolerance.
Canonical NF- ?B maintains the function and identity of mature Treg cells
We next investigated whether NF- ?B was continuously required for mature Treg function. 
We induced conditional deletion of p65 and c-Rel in peripheral Tregs by administrating 
tamoxifen to Rela- and Rel-floxed mice crossed with Foxp3eGFP-Cre-ERT2xRosa26stop-eYFP 
mice (Rubtsov et al., 2010) (Figure 5A). In these mice, all Tregs express Green Fluorescent 
Protein (GFP), but tamoxifen treatment induces expression of Cre and Yellow Fluorescent 
Protein (YFP), allowing isolation of NF- ?B deleted Treg cells by flow cytometry. We 
assessed Treg frequency seven days after initiating tamoxifen treatment. The percentages of 
FoxP3+ Tregs were significantly reduced upon deletion of Rel and Rel+Rela (Figure 5B), 
suggesting that NF- ?B played a role in the maintenance of Tregs or Treg identity. Moreover, 
the MFI of staining for FoxP3, as well as CD25 and GITR, was decreased in Tregs following 
inducible deletion of Rel or both Rel and Rela, but not in cells in which only Rela was 
deleted (Figure 5C). We also observed a loss of Foxp3 mRNA expression in Rel+Rela 
deleted cells (Figure 5D). These data suggested that canonical NF- ?B activity and, in 
particular c-Rel, was essential for the maintenance of the mature Treg population. We next 
tested the in vivo suppressive function of Treg cells with inducible deletion of Rel and Rela 
(induced-double knockout, iDKO Treg). Similar to Foxp3YFP-creRelaf/fRelf/f Tregs, iDKO 
(TMX-Foxp3eGFP-Cre-ERT2Rosa26stop-eYFPRelaf/fRelf/f) Tregs failed to prevent development 
of colitis in Rag1−/− mice (Figure 5E, F). This data established an essential role for NF- ?B 
in Treg function in vivo and suggested the canonical NF- ?B pathway may play an important 
role in the maintenance of Treg identity.
Canonical NF- ?B maintains the Treg transcriptome
The finding that NF- ?B was required for Treg suppressive function is consistent with NF- ?B 
being a key mediator of transcriptional events downstream of TCR ligation. However, it is 
unclear how NF- ?B fulfills this role in both Treg and Tconv cells. Our finding that loss of 
canonical NF- ?B in Tregs resulted in a loss of Treg function led us to hypothesize that NF-
 ?B controls a distinct, lineage specific, transcriptional program in Treg cells. To delineate 
the NF- ?B-dependent transcriptomes in Tregs we used high-throughput RNA-sequencing 
(RNAseq) analysis to compare the global gene expression patterns between Tregs of various 
genotypes and WT Tconv cells stimulated or not with anti-CD3 and anti-CD28. 
Unsupervised hierarchical clustering (Figure 6A) of the data by genotype indicated a 
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profound effect of NF- ?B on the Treg transcriptome. As expected, based on the disease 
phenotype observed, single deletions of Rela or Rel induced largely distinct perturbations in 
gene expression. Rela−/−Rel−/− Tregs were distinct from WT Tregs, Rela−/− and Rel−/− 
Tregs, clustering as an outlier group. Furthermore, we found that stimulated and 
unstimulated Tregs clustered together, segregating by genotype rather than by presence or 
absence of stimulation. When additional published Treg and Tconv datasets were included in 
clustering (Wakamatsu et al., 2013), Rela−/−Rel−/− Tregs clustered together with WT Tconv 
cells, emphasizing the loss of Treg signature gene expression upon NF- ?B deletion (Figure 
S5A). The distinct set of genes in Rela−/−Rel−/− containing loss of Treg signature genes was 
also observed in the clustering of our RNAseq dataset without public data, using the genes 
with ANOVA fold change higher than 1 (P < 0.05) (Figure S5B). Principal component (PC) 
analysis confirmed that Rela−/−Rel−/− Tregs exhibit a distinct transcriptome in comparison to 
either single knockout or WT Tregs (Figure S5C). While the first PC, accounting for 32.9% 
of the variance, established Rela−/−Rel−/− Tregs as having a divergent transcriptional profile, 
PC2 and PC3, together accounting for 31.2% of the variance, emphasized the transcriptional 
similarity between Rela−/−Rel−/− Treg and Tconv cells (Figure S5C). Consistent with both 
the PC analysis and clustering, we found that gene expression was equally impaired in 
unstimulated and stimulated Rela−/−Rel−/− Tregs (Figure 6B).
Although NF- ?B can both activate and repress gene expression, c-Rel and p65 are generally 
considered positive regulators of transcription. However, almost equal numbers of genes 
were up- and down-regulated upon loss of these NF- ?B subunits in Tregs (Figure 6C). We 
also found that the majority of genes differentially expressed in Rela−/−Rel−/− vs WT Tregs 
cells were not significantly altered in either Rel or Rela-deficient Tregs (Figure 6C). This, 
together with the partial phenotypic overlap resulting from Treg specific gene deletion 
(Figures 2 and 3), suggested considerable compensation between p65 and c-Rel. We found 
that numerous Treg signature genes were downregulated, and conversely expression of 
inflammatory cytokine transcripts increased, in Rela−/−Rel−/− Tregs compared to WT Tregs 
in both stimulated and unstimulated cells (Figure 6B, D). In particular, the expression of 
Ifng, Il17a, Il2, Il4 and Il13 was increased at the mRNA and protein levels in Rela−/−Rel−/− 
Tregs (Figure 6E, S5F). Gene set enrichment analysis (GSEA) revealed significant 
enrichment of Treg genes as well as chemokine, cytokine and transcription factor genes 
(Figure S5E). Within the Treg gene set, expression of Foxp3 as well as two transcription 
factors that act cooperatively with FoxP3, Ikzf2 (Helios) and Ikzf4 (Eos) were reduced in 
Tregs from Foxp3YFP-creRelaf/fRelf/f mice (Figure 6D, left panel, and S5F). Similarly, the 
Treg signature genes, Cd83, Gpr83 and Lrrc32 (GARP), were also downregulated in 
Rela−/−Rel−/− Tregs. Additional genes implicated in Treg homeostasis that were significantly 
altered in Rela−/−Rel−/− Tregs included chemokines and chemokine receptors, e.g. Ccr7 and 
Ccr6 (Figure S5E). These results suggested that deficiencies in Treg localization and 
recruitment may potentially explain why the defect in function of Treg lacking NF- ?B 
manifested in vivo, but not in vitro. We also noted that several cytokines such as Il22, Il4 and 
Il13, which are not expressed in WT Treg cells, were upregulated in Rela−/−Rel−/− Tregs and 
further increased upon TCR stimulation (Figure 6B, D and Figure S5D–F) As expression of 
Foxp3 was down-regulated in Rela−/−Rel−/− Treg cells, we also assessed whether the 
impairment of Rela−/−Rel−/− Treg transcriptome could be the consequence of FoxP3 loss 
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rather than a direct effect of NF- ?B ablation. Comparison of FoxP3-dependent genes (Gavin 
et al., 2007) with Rela−/−Rel−/− -affected genes revealed only a partial overlap (Figure S5G). 
While some prototypic Treg genes with decreased expression in Rela−/−Rel−/− Tregs, such as 
Ctla4 or Ikzf2, were FoxP3-dependent, GSEA of the 2653 Rela−/−Rel−/− -affected FoxP3-
independent genes also highlighted a loss of the Treg signature (Figure S5H). Thus, ablation 
of NF- ?B led to a loss of Treg identity not only indirectly through the down-regulation of 
FoxP3 expression but also by directly affecting expression of NF- ?B-dependent genes. As 
Foxp3YFP-creRelaf/fRelf/f mice develop an early systemic inflammatory syndrome, we then 
asked whether the altered gene expression in Rela−/−Rel−/− Tregs was due to the intrinsic 
absence of NF- ?B in the cells, or due to inflammatory cytokines in the local environment. 
The modest but significant increase of the expression of Ifng, Il5 and Il22 in Rel-deficient 
Tregs was a first indication that loss of NF- ?B subunits led towards a Teff-like phenotype 
independent of local inflammation as young Foxp3YFP-creRelf/f mice do not display any 
autoimmune phenotype (Figure 2). To further analyze the effect of NF- ?B-ablation 
independently of the local milieu, we deleted floxed Rela and Rel in vitro, using TAT-Cre. 
Gene expression patterns of control and iDKO Tregs were then compared by RNAseq. As 
observed upon in vivo deletion of NF- ?B, iDKO Tregs exhibited increased expression of 
various inflammatory cytokines such as Il17a, Il22, Ifng and Il4 (Figure 6F). Moreover, 
some hallmarks of Treg identity, such as Foxp3, Cd83 and Id3, were also down-regulated. 
This demonstrated that NF- ?B exerts a cell-intrinsic effect to maintain Treg identity and 
prevent the expression of Tconv-specific genes. Taken together, this analysis suggested that 
NF- ?B regulates distinct transcriptional programs in Treg and Tconv cells and demonstrated 
an important role for NF- ?B in maintenance of a lineage specific transcriptome in Tregs.
NF- ?B p65 directly coordinated the expression of Treg-signature genes
To characterize lineage specific, differential DNA binding patterns by NF- ?B in Treg and 
Tconv cells, we used chromatin immunoprecipitation with massively parallel DNA 
sequencing (ChIPseq). After identifying putative p65 occupancy sites using the 
Irreproducible Disovery Rate (IDR) framework (Li, 2011) as outlined by ENCODE, we 
compared the number of peaks between populations. A fraction of peaks were detected both 
with and without stimulation, and these were mostly overlapping between Treg and Tconv 
(Figure 7A). To define a more rigorous set of overlapping regions putatively bound by p65 
across all four conditions, we identified peaks in stimulated Treg cells that were also 
observed in stimulated Tconv cells, as well as in both unstimulated Treg and Tconv cells. We 
named this subset of 1571 peaks associated with 1297 genes “constitutive” because of the 
relatively high enrichment compared to input across all 4 samples (Figure 7B). GSEA on 
these “constitutive” p65-bound genes showed genes such as cell cycle-related genes (e.g. 
Cdk4 and Birc5) (Figure S6A). Interestingly, at a number of peaks, binding intensity was 
strongly increased upon stimulation in both Tconv and Treg similarly, confirming that NF-
 ?B activation and binding to chromatin is induced upon TCR+CD28 signaling (Figure 7A, 
B). We defined a set of shared peaks in both Treg and Tconv stimulated cells that were also 
differentially enriched in stimulated versus unstimulated Treg cells, but not significantly 
differentially occupied between Treg and Tconv (see Methods). We named this subset “Treg-
Tcon shared” and found that this gene set corresponding to 3552 genes was enriched for 
genes such as cytokines and cytokine receptors, e.g Tnf, as well as known NF- ?B-induced 
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genes such as Nfkbia (I ?B ?) (Figure S6B). We also detected a number of peaks that were 
significantly higher in stimulated Treg compared to Tconv. This final set of p65 peaks 
specific to stimulated Treg cells was defined by identifying stimulated Treg binding sites 
differentially enriched over both unstimulated Treg and stimulated Tconv cells. Of the 432 
genes putatively associated with these 859 peaks, several fall within the well-described set of 
Treg signature genes such as Foxp3, Ikzf2 and Lrrc32 (Figure 7F). GSEA of this “Treg-stim 
enriched” population was enriched in genes highly expressed in Treg versus Tconv (Figure 
S6C). Only a few peaks were specifically detected in stimulated Tconv but not Treg cells, 
suggesting that p65 binding could be influenced by a Treg-specific environment that does 
not exist in a Tconv-specific landscape. The distribution of peak distances from the nearest 
transcription start site (TSS) and the distribution of genomic annotations associated with 
those peaks showed significant variation between different samples (Figure S6D). In contrast 
with constitutive peaks, Treg stim-enriched peaks showed marked increase in the fraction of 
peaks located in distal intergenic regions, suggesting that they might be binding to putative 
enhancers. These peaks contributed to the overall increase in Treg stim peaks (Figure 7A). 
Our data demonstrated that TCR+CD28-induced NF- ?B binding is different in Treg and 
Tconv, suggesting that the Treg-lineage environment influences NF- ?B binding and 
function.
We next looked for p65 binding motif enrichment in each gene subset using SeqGL (Setty 
and Leslie, 2015), as described in Methods. We found an enrichment for a Rel Homology 
domain-like motif nearby both Treg stim-enriched and Treg-Tcon shared summits (Figure 
7C). The peaks shared by Tconv and Treg were enriched with motifs for various 
transcription factors such as CREB, ETS and RUNX1 in addition to NF- ?B REL-binding 
motifs (Figure 7C). On the other hand, Treg-enriched peaks were predominantly enriched 
only with REL-binding motifs. This suggests that preferential binding of p65 to those sites 
in Treg over Tconv may not be due to unique unconventional binding motifs.
We then analyzed whether Treg-specific p65-binding could simply rely on a differential 
chromatin accessibility in Treg and Tconv cells. DNase hypersensitivity (HS) experiments 
have previously demonstrated a discrete chromatin accessibility in Treg and Tconv 
(Samstein et al., 2012). To assess a possible role for accessibility in p65-binding, we aligned 
their DNase HS sequencing data in Treg and Tconv cells to our p65 ChIPseq dataset. 
Interestingly, in Treg-enriched peaks, chromatin accessibility was significantly higher in 
Treg versus Tconv, whereas the opposite trend was observed in Treg-Tconv shared peaks 
(Figure 7D). This was illustrated by higher DNase HS signals in Treg at numerous Treg-
associated genes, such as Foxp3, Ikzf2 or Lrrc32 (Figure 7G). Similar results were obtained 
when using a recently reported (Kitagawa et al., 2017) ATAC-Seq dataset (Figure 7E). This 
correlation suggests that chromatin accessibility yields increased p65 binding at Treg-
enriched loci, resulting NF- ?B-dependent regulation of the Treg specific transcriptional 
program.
To further elucidate the direct contribution of p65 binding to the differential gene expression 
of Tconv and Treg cells, we next focused our analysis on Treg and Tconv specific genes. We 
first defined a set of 587 “Treg signature” genes whose expression was significantly higher 
in WT Treg than WT Tconv, based on public datasets (Ye et al., 2014) (Figure 7F). As a 
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counterpart, we used a “Tconv signature” set composed of 211 genes, as well as the total 
coding genome. We assessed the potential association between p65 binding at Treg-stim 
enriched, Treg-Tcon shared and constitutive peaks, FoxP3 binding peaks (Samstein et al., 
2012), Tconv—Treg and Treg Rela−/−Rel−/− —WT differentially expressed genes, and 
Tconv—Treg signature genes. We found a strong enrichment of Treg-specific p65 binding in 
Treg-signature genes. Expression of many of these genes was dependent on NF- ?B, as their 
expression was down-regulated in Rela−/−Rel−/− Tregs (Figure 7F). Interestingly, the fraction 
of genes bound by both FoxP3 and p65 was higher in Treg-signature genes than in the rest of 
the genome (Figure 7F and S6E), further underlining the importance of these transcription 
factors in Treg-specific gene expression. This was illustrated by FoxP3 binding in the 
vicinity of p65 binding at Foxp3, Ikzf2 and Lrrc32 loci (Figure 7G). Taken together, our 
results showed that NF- ?B directly directed the expression of Treg-essential genes by 
accessing specific, open loci in Treg cells.
DISCUSSION
Even though Tconv and Treg cells develop from the same pool of thymocyte progenitor 
cells, they have diametrically opposed functions in the immune system. Consistent with their 
common developmental lineage, Treg and Tconv cells share many of the same cell surface 
receptors and intracellular signaling pathways. This common nature of T cell signaling 
events in both Treg and Tconv cell represents a significant barrier to the development of 
immunomodulatory therapies. Thus, targeting of a common signaling mechanism in both 
cell types may result in a single agent simultaneously promoting and inhibiting Tconv 
responses. Given the importance of Tregs in both beneficial peripheral tolerance and 
detrimental tumor tolerance, it is therefore essential that we understand how the same TCR 
signaling leads to such different biological functions in Treg and Tconv cells.
It has been proposed that activation of the canonical NF- ?B pathway upon TCR and CD28 
triggering is important for normal Treg differentiation. For instance, mice lacking any 
member of the CARMA-1-Bcl-10-Malt1 complex exhibit a profound lack of FoxP3+ 
thymocytes (Molinero et al., 2009), whereas constitutive activation of NF- ?B through an 
IKKEE transgene in T cells increases thymic Treg cells (Long et al., 2009). Furthermore, 
germline deletion of c-Rel leads to reduced transition into the Treg progenitor step and 
subsequent maturation into FoxP3+ Treg cells (Grigoriadis et al., 2011; Isomura et al., 
2009). However, deletion of Rel does not fully eliminate Treg cells, leaving unclear the role 
of the canonical NF- ?B pathway. The study of Rela−/− mice was complicated by the 
embryonic lethality of these mice although indirect evidence pointed towards a role for p65 
in FoxP3 expression (Deenick et al., 2010; Isomura et al., 2009; Soligo et al., 2011). In the 
current study, we demonstrated a crucial requirement for both canonical NF- ?B subunits in 
the generation of FoxP3− Treg precursors. Canonical NF- ?B signaling, along with IL-2 to 
STAT-5 and I ?B-NS signals (Lio and Hsieh, 2008; Schuster et al., 2012), is crucial for the 
subsequent expression of FoxP3 and for mature Treg homeostasis in secondary lymphoid 
organs. We also showed a partial redundancy as absence of both p65 and c-Rel led to nearly 
complete abolishment of Treg cells in the thymus and the periphery.
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To date, only a moderate role for NF- ?B was previously described in the in vitro iTreg 
polarization (Jana et al., 2009; Visekruna et al.). Here we showed that naïve T cells fully 
lacking canonical NF- ?B were unable to give rise to iTreg, even in the presence of 
exogenous IL-2, while deletion of only Rela or Rel had nearly no effect. Thus, our studies 
demonstrated a redundant but crucial role for canonical NF- ?B activity in iTreg 
development and highlighted a specific role for each NF- ?B subunit in Treg development in 
vivo and in vitro.
To examine the role of NF- ?B in Tregs more precisely, we performed Treg-specific 
conditional deletion of Rela and/or Rel. The profound autoimmunity observed upon deletion 
of Rela in Tregs was consistent with recently reported results (Messina et al., 2016). 
However, these mouse models showed that both p65 and c-Rel played essential, although 
partially redundant, roles in the function of Treg cells. In contrast to its essential role in Treg 
development, we observed little effect of Rel deletion on the ability of Tregs to suppress 
systemic lymphoproliferative disease. In contrast, mice in which both subunits are deleted in 
Treg cells display a Scurfy-like phenotype with severe lethal lymphoproliferative and 
autoimmune disease despite only modest reductions in Treg numbers. Therefore, canonical 
NF- ?B is essential for the function of both Treg and Tconv cells.
The graded phenotype observed in mice lacking c-Rel, p65, or both NF- ?B subunits in Treg 
offers some hints as to the relative importance of specific canonical NF- ?B regulated genes 
in Treg function. That is, while Foxp3YFP-creRelaf/fRelf/f mice exhibit a Scurfy-like 
phenotype, mice lacking Rela in Tregs display a relatively delayed, though still severe 
phenotype, while mice lacking only Rel in Tregs show a substantially delayed and mild 
phenotype. Thus, it might be expected that an analysis of gene expression between 
genotypes would be instructive in understanding the basis of this graded phenotype. 
Although expression of specific candidate genes known to be important for Treg function 
were clearly altered, it seemed that graded changes in expression of several target genes, 
likely due to partial compensation between canonical NF- ?B subunits, accounted for the 
difference in Treg suppressive phenotypes observed. When the canonical NF- ?B pathway 
was completely ablated in Treg cells by deleting both Rela and Rel, Tregs not only lost 
suppressive function and their expression of Treg-signature genes but also upregulated the 
expression of certain Tconv genes, especially inflammatory cytokines. This was due to a 
specific function of c-Rel, as Rel-deficient Tregs, but not Rela-deficient Tregs, displayed 
increased expression of Ifng among the cytokines. These data suggested that in Tregs, c-Rel, 
specifically, was essential for the suppression of effector cytokine expression. Further 
analysis of the functions of c-Rel and p65 in Tregs demonstrated a unique role for c-Rel in 
activated Treg function and maintenance of tumor tolerance (Grinberg-Bleyer et al., 2017). 
Overall, canonical NF- ?B regulated a lineage specific transcriptome comprising of multiple 
genes with a broad role in the maintenance of Treg identity and function, which suppressed a 
conventional CD4+ T cell phenotype in Tregs.
While canonical NF- ?B is well-known to be critical for effector cell differentiation and 
expression of inflammatory cytokines in Tconv cells, our findings indicate that the same 
signaling pathway regulated a dissimilar lineage defining transcriptional program in Treg 
cells. Thus, the canonical NF- ?B pathway, in both cases activated through ligation of the 
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same TCR complex, activated a qualitatively and quantitatively distinct transcriptional 
program with opposing biological functions. Two potential mechanisms help explain the 
divergent role of canonical NF- ?B in Treg and Tconv cells: the extent of NF- ?B activation 
and access to  ?B DNA binding sites. Tregs depend on constitutive TCR signaling for 
maintenance of suppressive function (Levine et al., 2014). Thus, we, like others (Messina et 
al., 2016), saw higher levels of nuclear canonical NF- ?B subunits in circulating Tregs 
compared to Tconv cells, consistent with an ongoing role for NF- ?B in the regulation of the 
Treg specific transcriptome (data not shown). However, increased canonical NF- ?B 
activation in Tregs compared with Tconv cells did not account for the divergent 
transcriptional programs regulated by NF- ?B in the two cell types. TCR ligation induced 
equivalently robust canonical pathway activation in both cell types, yet NF- ?B regulated 
distinct sets of genes in Treg and Tconv cells. This suggested that changes in the chromatin 
landscape in Treg cells might be a major determinant of Treg identity. Consistent with this 
idea, NF- ?B p65 ChIP-seq identified substantial differences in chromatin binding between 
Treg and Tconv cells, following TCR stimulation. In particular, the number and intensity of 
many peaks were higher in Treg cells compared to Tconv cells. These Treg-enriched peaks 
were often found in Treg-associated genes, such as Foxp3 or Ikzf2, further confirming a 
direct Treg-lineage specific role for NF- ?B. This specific binding was not due to an altered 
binding motif. However, DNase-seq and ATAC-seq analyses revealed greater chromatin 
accessibility in Treg than Tconv cells at these loci. This suggested that lineage-associated 
p65-binding relied on a Treg-specific chromatin structure rather than on a specific DNA 
sequence.
The molecular mechanism driving distinct p65 binding in Treg cells remains to be 
elucidated. A possibility is that other Treg-specific transcription factors may drive NF- ?B 
activity, or cooperate with p65, to regulate Treg gene expression. Given that FoxP3 is the 
lineage specific transcription factor that differentiates Treg and Tconv cells, it is possible 
that FoxP3 itself coordinates Treg-specific p65-binding and activity. It was previously 
suggested that FoxP3 and p65 may influence NF- ?B activity, for instance on the GITR locus 
(Tone et al., 2014). Analysis of our ChIPseq and public data showed binding for both p65 
and Foxp3 on multiple Treg genes, including Foxp3 itself, Ikzf2, Lrrc32 or Ctla4. Other 
transcription factors, such as Foxo1/3 or ETS-1, were also suggested to influence the 
expression of NF- ?B-dependent Treg signature genes (Kerdiles et al., 2010; Ouyang et al.; 
Samstein et al., 2012). This suggests that other lineage specific factors likely also 
contributed to the lineage-specific transcriptional program regulated by canonical NF- ?B. 
Understanding how different chromatin modifying and transcription factors orchestrate the 
establishment of a Treg-specific transcriptome would be of great interest.
In summary, our studies demonstrated an absolute requirement for canonical NF- ?B for 
regulatory T cell function in vivo. Given the known roles of canonical NF- ?B in 
conventional T cell responses, these data suggested that considerable caution is need for the 
development of immunomodulatory therapeutics that target the NF- ?B pathway. In this 
regard, the differential roles of p65 and c-Rel in Tregs, identified here, as well as in B and T 
cell immune responses, previously described, suggest that approaches that selectively target 
specific components of the NF- ?B signaling pathway may have greater utility compared to 
inhibitors that shut down the entire pathway, e.g. inhibitors that target IKK. Finally, these 
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studies demonstrated an intriguing functional plasticity for the NF- ?B pathway where even 
within closely related cellular lineages, the same NF- ?B subunits could regulate highly 
divergent transcriptional programs with profound biological ramifications.
STAR Methods
CONTACT FOR REAGENT AND RESCOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be 
fulfilled by the Lead Contact, Sankar Ghosh (sg2715@cumc.columbia.edu).
EXPERIMENTAL MODELS
Mice—Relaf/f mice were obtained from Roland Schmid (Munich, Germany) (Algul et al., 
2007) and Relf/f mice from Ulf Klein (Columbia University, New York)(Heise et al., 2014). 
FoxP3cre mice were originally purchased from Jackson laboratory. FoxP3eGFP-Cre-ERT2 x 
Rosa26stop-eYFP mice were obtained from A. Rudensky and crossed with Relaf/f and Relf/f 
mice. All the mice were bred in the specific-pathogen-free (SPF) facility at Columbia 
University (New York, NY). Rag1−/− mice were originally purchased from Jackson 
laboratory and bred and maintained at our animal facility. 5–8 weeks-old male or female 
mice were used for most of experiments but 18–28 days-old mice were used to analyze 
FoxP3creRelaf/fRelf/f mice due to their early mortality. To analyze old FoxP3creRelf/f mice, 
7–8 months mice were used. All experiments were performed following the animal protocol 
approved by Institutional Animal Care and Use Committee of Columbia University 
(protocol AAAI 4700).
METHOD DETAILS
Cell Isolation—Cells were isolated from spleens and lymph nodes by grinding with cell 
strainers. For isolation of cells from the intestine, colons were collected and cut into small 
pieces after being cleaned up. Intestinal pieces were incubated in PBS containing 5 mM 
EDTA and 10 mM HEPES at 37°C with shaking for 20 minutes twice to acquire intestinal 
epithelial cells. Remaining pieces were digested with culture media containing 1 mg/ml 
collagenase type IV (Sigma) and 1mg/ml DNase I (Sigma) at 37°C for 15 minutes twice to 
acquire lamina propria cells. Lymphocytes were isolated by Percoll gradient from isolated 
cells. For isolation of cells from lungs, lungs were cut into small pieces and digested in 
culture media containing Collagenase and DNase I at 37°C. Then, digested lung fragments 
were passed through cell strainers to get single cell suspensions. Lymphocytes were isolated 
by Percoll gradient.
Flow Cytometry and Sorting—Isolated cells were stained with  ?CD4,  ?CD8,  ?CD3, 
 ?TCR ?,  ?CD44,  ?CD62L,  ?FoxP3,  ?IL-17 and  ?IFN- ?(eBioscience and Tombo). For 
FoxP3 and cytokine staining, cells were stained according to the manufacturer’ s protocol 
form FoxP3 staining kit (Affimetrix/eBioscience). For cytokine staining, cells were 
stimulated with 50 ng/ml PMA and 1 μg/ml ionomycin in the presence of GolgiPlug (BD 
Bioscience) for 4 hours at 37°C and stained for surface markers followed by fixation/
permeabilization and staining for cytokines. Stained cells were acquired with LSRII or LSR 
Fortessa cytometers; data was analyzed using FlowJo (Treestar) (BD Bioscience). For 
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sorting of Treg cells, CD4+ T cells were enriched by using mouse CD4+ T cell isolation kit 
(Miltenyi) or Magnisort mouse CD4+ T cell enrichment kit (Affimetrix/eBioscience) and 
then cells were sorted by FACSAria (BD Bioscience).
In vitro Treg differentiation—CD4+CD44lowCD25− naïve T cells were FACS-sorted 
from splenocytes suspensions. 105 T cells were cultured in complete RPMI (Gibco) with 105 
T-cell depleted, mitomycin C-treated WT splenocytes and 2.5 μg/mL anti-mCD3 
(BioXCell), in the presence of 10 ng/mL mIL-2 (Peprotech) and grading doses of human 
TGF- ?1 (Peprotech), for 4 days at 37C. Cells were then stained for flow cytometry analysis.
Western Blotting—Total lysates were extracted using RIPA buffer and protease inhibitors 
with SDS. 20 μg protein extracts were resolved in polyacrylamide gels and transferred onto 
PVDF membranes. Membranes were incubated with anti-p65, c-Rel (Santa-Cruz) and 
GAPDH (Fitzgerald) Abs, followed HRP-coupled secondary Abs.
In Vivo Suppression Assay—Tconv cells were sorted from wild type mice and Treg 
cells were sorted from wildtype or conditional knockout mice. 4 × 105 Tconv cells were 
transferred to RAG1 mice by i.v. injection together with wild type or knockout Treg cells (1 
× 105). Tconv cells were also transferred without Treg cells as a control group. Weight was 
monitored weekly after adoptive transfer to observe progression of disease. Mice were 
euthanized when some of them reached 20% reduction of initial weight, and colons and 
other lymphoid organs were collected for H&E staining and flow cytometric analyses.
In Vitro Suppression Assay—Tconv cells were sorted from wildtype mice and Treg 
cells were sorted from wildtype or conditional knockout mice. Tconv and Treg cells were 
co-cultured at different ratios of Tconv:Treg in the presence of anti-CD3 and anti-CD28 
antibodies. Tconv cells were also cultured without Treg cells as a control. Cells were 
cultured for 3 days and 1 μCi of 3H-thymidine was added to each well 8 hours before 
harvest. T cell proliferation was observed by measuring the incorporation of 3H-thymidine 
by the scintillation counter.
Quantitative RT-PCR (qRT-PCR)—RNA was prepared from cells by using RNeasy Mini 
Kit or RNeasy Plus Mirco Kit (Qiagen). cDNAs were synthesized by using SuperScript III 
(Invitrogen) and quantitative PCR was performed by using SYBR Green (Quanta 
Biosciences) using a CFX96 or CFX384 Thermal Cycler (BioRad). Expression level was 
normalized by GAPDH or tubulin.
Inducible deletion of genes by tat-cre treatment—Cells were resuspended in 
ADCF-Mab serum free media (HyClone) and Tat-cre (Protein and Proteomics Core Facility, 
The Children’ s Hospital of Philadelphia) was also diluted in ADCF-Mab media to 100 μg/ml 
concentration. Cell suspension and Tat-cre solution were prewarmed for 10 minutes at 37°C 
and then mixed at a 1:1 ratio. Mixture of cells and Tat-cre was incubated for 45 minutes at 
37°C. Transduction was stopped by adding growth media containing 10% FCS. Cells were 
washed again with growth media containing 10% FCS and returned to culture.
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Inducible deletion of genes by tamoxifen treatment—Tamoxifen in corn oil was 
administered by i.p. injection three consecutive days with 4 mg per mouse. After one week, 
mice were euthanized and cells with deletion were isolated by FACS based on expression of 
YFP from tamoxifen-inducible ROSA-floxed system. Isolated cells were then used for 
further experiments.
Histology—Mouse tissues were fixed in 10% formalin and stored in 70% ethanol until 
staining. All the fixed tissues were embedded in paraffin, sliced and stained by H&E in 
Histology Core at Columbia University Medical Center. Disease severity score was 
determined by severity of immune cell infiltration: >4 (most severe), 2 to 3 (severe), 1 
(mild), and 0 (none). For ears, thickness of ear skin was measured after taking photos of 
H&E staining in AxioVision software.
RNAseq—Tconv and Treg cells were sorted from various mouse strains and stimulated 
with 5 μg/ml plate-bound anti-CD3 and 1 μg/ml anti-CD28 antibodies for three hours in the 
presence of IL-2 (Peprotech). 2 ng/ml IL-2 was added to Tconv culture and 10 ng/ml IL-2 
was added to Treg culture. Cells were harvested and RNA samples were prepared. Quantity 
and quality of RNA samples were measured by Bioanalyzer (Molecular Pathology core at 
Herbert Irving Comprehensive Cancer Center, Columbia University). Library construction 
and sequencing were done by Columbia Genome Center. Poly-A pull-down was used to 
enrich mRNAs from total RNA samples and libraries were prepared by using Illumina 
TruSeq RNA prep kit. Libraries were then sequenced using Illumina HiSeq2000. All the 
RNAseq analyses except one set (paired-end 60 million reads) were single-end 30 million 
reads.
Chromatin immunoprecipitation (ChIP) assay for sequencing—T cells were fixed 
with 1% formaldehyde (Sigma) for 10 minutes at room temperature, quenched with 0.125 M 
glycine for 10 minutes and then washed in PBS. Fixed cells were lysed in Cell lysis buffer 
(25 mM HEPES pH 7.8, 1.5 mM MgCl2, 10 mM KCl, 0.1% NP-40) with freshly added 1 
mM DTT and protease inhibitors by incubating on ice for 10 minutes. Lysates were 
centrifuged at 5400 rpm for 5.5 min for nuclei isolation. Isolated nuclei were lysed in 
Nuclear lysis buffer. Nuclei lysates were sonicated by Bioruptor (Diagenode). Anti-p65 
antibody (C-20, Santa Cruz Biotechnology) was incubated with Dynabeads™ protein A 
(Invitrogen) to prepare antibody-bound beads. Sonicated lysates were mixed with antibody-
bound beads and immunoprecipitated overnight at 4°C. Beads were washed and incubated 
with RNase for 30 min at 37°C followed by incubation with proteinase K for 2 hours. Then, 
beads were decrosslinked overnight at 65°C and immunoprecipitated DNA fragments were 
isolated by QIAquick PCR purification kit (Qiagen). Small aliquots of DNA samples were 
used for qPCR to confirm the efficiency of ChIP reaction. The concentration of 
immunoprecipitated DNA and input DNA was determined by Bioanalyzer.
ChIP sequencing (Illumina)—Library preparation and sequencing were performed by 
Admera Health. Library was constructed on immunoprecipitated DNA according to 
manufacturer’ s recommendations (KAPA Hyper Prep Kit). Samples were enriched with 
PCR with 12 cycles (Eppendorf Mastercycler ep gradient S; Eppendorf AG, Hamburg, 
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Germany) with the program suggested on the commercial kit manual. Afterward, double size 
selection was performed with AMPure XP beads (Beckman Coulter, High Wycombe, UK) 
for a final library size of 500 bp. After pooling and denature, the samples were sequenced on 
the HiSeq with a 150 PE read length configuration.
Preliminary processing of sequencing data—Raw FASTQ reads were initially 
removed of adapter and low base quality contamination using Trim Galore! v0.4.1 (https://
www.bioinformatics.babraham.ac.uk/projects/trim_galore/), which implements 
cutadapt(Martin, 2011) (http://cutadapt.readthedocs.io/en/stable/index.html) as the 
underlying base removal algorithm. Trimmed reads were subsequently aligned using BWA 
mem(H. Li and Durbin, 2009) (http://bio-bwa.sourceforge.net/). Post-alignment 
preprocessing was performed with the Picard suite of tools (http://broadinstitute.github.io/
picard/), ‘ IndelRealigner’  and ‘ MarkDuplicates’ , and samtools(H. Li et al., 2009) (http://
samtools.sourceforge.net/). Aligned reads with non-zero mapping quality were retained in 
BAM format. Genome-wide coverage tracks were produced using the deepTools 
v2.3.6(Ramirez et al., 2016) (http://deeptools.readthedocs.io/en/latest/#) ‘ bamCoverage’  
function with 50bp bins and an effective genome size of 2,451,960,000 bases and scaled to 
1X coverage based on the number of reads mapped to autosomal chromosomes. Coverage 
was calculated from reads extended to estimate fragment size as determined by the cross-
correlation analysis provided by the ‘ phantompeakqualtools’  package (https://
www.encodeproject.org/software/phantompeakqualtools/). Coverage signal was further 
summarized by taking the mean across replicates within groups. In the case of the public 
DNase I hypersensitivity data, mean coverage signal was additionally quantile normalized 
between Treg and Tconv cell types using the ‘ normalize.quantiles’  function from the 
‘ preprocessCore’  R package. All signal and peak results were visualized in genomic context 
using the WashU EpiGnome Browser(Zhou et al., 2011) (http://
epigenomegateway.wustl.edu/).
Identification of regions of enrichment (peak-calling)—MACS 
v2.1.1.20160309(Yong Zhang et al., 2008) (https://github.com/taoliu/MACS) was used for 
peak identification within the Irreproducible Discovery Rate (IDR) framework described by 
the ENCODE project(Q. Li et al., 2011; Landt et al., 2012) (https://sites.google.com/site/
anshulkundaje/projects/idr) to produce a single consensus peak call set for each replicate 
group, using appropriate ChIP/input pairs when applicable. In brief, ‘ macs2 callpeak’  at a 
permissive p-value threshold of 0.1 for various permutations of the replicate data, 
independent, combined, and in several pseudo-replicate combinations, to ascertain an 
appropriate threshold to make peaks calls utilizing the total combined replicate data. We 
chose to apply the more strict “conservative” threshold to identify our peak call sets.
Peak annotation—Consensus IDR peak calls were further characterized using the 
bedtools suite v2.25.0-24-g3d31735-dirty(Quinlan and Hall, 2010) (http://
bedtools.readthedocs.io/en/latest/). For more rigorous peak comparisons, we employed the 
PePr algorithm(Yanxiao Zhang et al., 2014) (https://github.com/shawnzhangyx/PePr) to 
identify significantly differential occupied or accessible regions. PePr models read counts 
using a negative binomial distribution with a dispersion parameter determined based on 
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proximal regions. Peak associations with genes and genomic feature classes (promoter, 
intron, exon, etc.) were determined using the ChIPseeker(Yu et al., 2015) R package. We 
allowed a more strictly defined range of within 10kb upstream or 5kb downstream of the 
most proximal gene to determine binding status of that gene when producing results 
comparing association of peak and expression features with Treg and Tconv signatures.
Differential detection—To identify enriched sequences associated with p65 binding 
peaks, we used the SeqGL(Setty and Leslie, 2015) R package, which identifies nucleotide k-
mers that discriminate positive peak sequences from negative sequences using logistic 
regression with sparse group lasso applied to related k-mer groups. We used both the default 
negative sequences of regions flanking peak summits (+/−150bp) but also provided custom 
sequences when appropriate. Additionally, SeqGL associates enriched k-mer groups to 
known binding motifs with the HOMER motif finding algorithm(Heinz et al., 2010) (http://
homer.ucsd.edu/homer/index.html). We report the SeqGL output which includes computed 
score for groups of k-mers along with the most similar known motif.
RNA-seq analysis—The reads were aligned with STAR v2.4.0c (Dobin et al., 2013), and 
genes annotated in Gencode v18 were quantified with featureCounts v1.4.3-p1(Liao et al., 
2014). Normalization and differential expression was done with the Bioconductor package 
DESeq2(Love et al., 2013).
Transposase-assessible chromatin (ATAC)-seq analysis—Publicly available 
ATAC-seq raw data for Treg and Tconv were obtained from a previous study (Kitagawa et 
al., 2017). Sequencing alignment was performed using Bowtie2 (Langead et al., 2012), and 
further analyzed by samtools in a general pipeline. ATAC-seq peaks were detected using 
HOMER. Annotation of normalized ATAC-seq peaks to ChIP-seq peaks in Treg and Tconv 
cells were performed using the annotatePeaks.pl program in HOMER package.
QUNATIFICATION AND STATISTICAL ANALYSIS
We used the unpaired Student t-test for two comparison groups. N represents the number of 
animals. Detailed description of statistics for each figure can be found in the figure legend. 
5-way ANOVA was used to analyze the replicates of RNAseq.
To compare DNase I hypersensitivity signals in Treg and Tconv, we calculated the mean, 
quantile normalized, library-size normalized coverage signals using the ENCSR000COC 
and ENCSR000COA, respectively, from data made available by the mouse ENCODE 
Project. We calculated Mann-Whitney U test p-values comparing the Treg to Tconv signal 
over +/−150bp around peak summits for each peak set. We evaluated statistically associated 
features within the context of the previously described 587 Treg and 211 Tconv signature 
genes. One-sided Fisher exact tests were performed comparing the count of genes with 
affirmative binary status with regards to presence of an associated peak (within upstream 
10kb to downstream 5kb), significant over-expression in Treg compared Tconv or WT 
compared to c-Rel/p65 DKO, or a member of the Treg signature instead of the Tconv 
signature.
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KEY RESOURCES TABLE
REAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
Anti-mouse CD4, APC-eFluor 780 
conjugated, clone RM4-5
eBioscience Catalog #47-0042-82
Anti-mouse CD8a, PE-CF594 
conjugated, clone 53.6.7
BD Biosciences Catalog #562315
Anti-mouse CD44, APC conjugated, 
clone IM7
Tonbo Biosciences Catalog #20-0441
Anti-mouse CD62L, PE conjugated, 
clone MEL14
eBioscience Catalog #12-0621-81
Anti-mouse CD25, APC conjugated, 
clone PC61.5
Tonbo Biosciences Catalog #20-0251
Anti-mouse GITR, PE-Cy7 
conjugated, clone DTA-1
eBioscience Catalog #25-5874-80
Anti-mouse IFN ? PE conjugated, 
clone XMG1.2
BD Biosciences Catalog #554412
Anti-mouse IL-17A APC conjugated, 
clone 17B17
eBioscience Catalog #17-7177-81
Anti-mouse FoxP3 eFluor 450 
conjugated, clone FJK16S
eBioscience Catalog #48-5773-82
Polyclonal anti-p65, unconjugated, 
clone C-20
Santa Cruz p65 C-20
Polyclonal anti-C-Rel, unconjugated, 
clone sc71
Santa Cruz c-Rel SC-71
Monoclonal anti-mouse GAPDH, 
unconjugated, clone 6C5
Fitzgerald Catalog #10R-G109a
In vivo mAb anti-mouse CD3, clone 
145-2C11
BioXCell Catalog #BE0001-1
Anti-mouse CD28, Na/Le BioLegend Catalog #102102
Bacterial and Virus Strains
Biological Samples
Chemicals, Peptides, and Recombinant Proteins
IL-2, murine Peprotech Catalog #212-12
TGF- ?1, human Peprotech Catalog #100-21C
Tat-cre Protein and 
Proteomics Core 
Facility, The 
Children’ s 
Hospital of 
Philadelphia
N/A
ADCF-Mab media HyClone/GE Catalog #SH30349.01
Formaldehyde solution Sigma Catalog #F8775
Dynabeads Protein A Invitrogen Catalog #10002D
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REAGENT or RESOURCE SOURCE IDENTIFIER
PMA salt Sigma Catalog #P8139
Golgi Plug protein transport inhibitor BD Biosciences Catalog #555029
Superscript IV reverse transcriptase Invitrogen Catalog #18090050
Veriquet Fast SYBR Fluor Affymetrix Catalog #75675
Ionomycin salt Sigma Catalog #10634
Collagenase type IV form 
C.Histolyticum
Sigma Catalog #C5138
DNAse I from bovine pancreas Sigma Catalog #DN25
Critical Commercial Assays
Magnisort mouse CD4 T cells 
enrichment kit
eBioscience Catalog #8804-6821
Qiagen RNeasy Mini Kit Qiagen Catalog #74106
Qiagen RNeasy Micro Kit Qiagen Catalog #74004
CD4+ T cell isolation kit, mouse Miltenyi Catalog #130-104-454
Deposited Data
RNAseq GEO GSE82076
ChIPseq GEO GSE99319
Experimental Models: Cell Lines
Experimental Models: Organisms/Strains
Mouse: Rel-Flox (Ulf Klein) Heise et al., 2014 N/A
Mouse: Rela-Flox (Roland Schmid) Algul et al., 2007 N/A
Mouse: Foxp3tm4(YFP/icre)Ayr/J Jackson laboratory Stock #016959
Mouse: Foxp3tm9(EGFP/cre/ERT2)Ayr/J Jackson laboratory Stock #016961
Mouse: Gt(ROSA)26Sortm1(EYFP)Cos/J Jackson laboratory Stock #006148
Mouse: Cd4cre Jackson laboratory Stock #022071
Mouse: Foxp3RFP (Foxp3tm1Flv/J) Jackson laboratory Stock #008374
Mouse: Rag1tm1Mom/J Jackson laboratory Stock #002216
Oligonucleotides
Primer: FoxP3 forward: 
CCCATCCCCAGGAGTCTTG
Eurofins Genomics
Primer: FoxP3 reverse: 
ACCATGACTAGGGGCACTGTA
Eurofins Genomics
Primer: Ikzf2 forward: 
GAGCCGTGAGGATGAGATCAG
Eurofins Genomics
Primer: Ikzf2 reverse: 
CTCCCTCGCCTTGAAGGTC
Eurofins Genomics
Primer: Ikzf4 forward: 
TCTGGACCACGTCATGTTCAC
Eurofins Genomics
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REAGENT or RESOURCE SOURCE IDENTIFIER
Primer: Ikzf4 reverse: 
ACGATGTGGGAAGAGAACTCATA
Eurofins Genomics
Primer: Cd83 forward: 
CGCAGCTCTCCTATGCAGTG
Eurofins Genomics
Primer: Cd83 reverse: 
GTGTTTTGGATCGTCAGGGAATA
Eurofins Genomics
Primer: Eomes forward: 
GCGCATGTTTCCTTTCTTGAG
Eurofins Genomics
Primer: Eomes reverse: 
GGTCGGCCAGAACCACTTC
Eurofins Genomics
Primer: Il13 forward: 
CCTGGCTCTTGCTTGCCTT
Eurofins Genomics
Primer: Il13 reverse: 
GGTCTTGTGTGATGTTGCTCA
Eurofins Genomics
Recombinant DNA
Software and Algorithms
Prism GraphPad software graphpad.com
FlowJo FlowJo LLC flowjo.com
Trim Galore! v0.4.1 https://www.bioinformatics.babraham.ac.uk/projects/trim_galore/
BWA mem H. Li and Durbin, 
2009
http://bio-bwa.sourceforge.net/
Picard suite of tools http://broadinstitute.github.io/picard/
samtools H. Li et al., 2009 http://samtools.sourceforge.net/
deepTools v2.3.6 Ramírez et al., 
2016
http://deeptools.readthedocs.io/en/latest/#
phantompeakqualtools https://www.encodeproject.org/software/phantompeakqualtools/
R https://www.r-project.org/
WashU EpiGnome Browser Zhou et al., 2011 http://epigenomegateway.wustl.edu/
MACS v2.1.1.20160309 Yong Zhang et al., 
2008
https://github.com/taoliu/MACS
Irreproducible Discovery Rate (IDR) 
framework
Q. Li et al., 2011; 
Landt et al., 2012
https://sites.google.com/site/anshulkundaje/projects/idr
bedtools suite v2.25.0-24-g3d31735-dirty Quinlan and Hall, 
2010
http://bedtools.readthedocs.io/en/latest/
PePr algorithm Yanxiao Zhang et 
al., 2014
https://github.com/shawnzhangyx/PePr
ChIPseeker Yu et al., 2015
SeqGL Setty and Leslie, 
2015
HOMER motif finding algorithm Heinz et al., 2010 http://homer.ucsd.edu/homer/index.html
STAR v2.4.0c Dobin et al., 2013
featureCounts v1.4.3-p1 Liao et al., 2014
Bioconductor package DESeq2 Love et al., 2013
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Other
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Discrete NF- ?B subunits control sequential steps of Treg cell development
(A–B) Thymii from 5–7 weeks-old Cd4cre mice crossed to mice bearing floxed alleles of 
Rela and Rel, were analyzed by flow cytometry. (A) Representative dot plots of gated live 
CD4+CD8−FoxP3− (top) and CD4+CD8− cells (bottom). Numbers indicate the % of cells in 
each gate. (B) Absolute numbers of CD4+CD8−FoxP3−CD25+GITR+ Treg precursors (left) 
and CD4+CD8−FoxP3+ Treg cells. (C) CD4+CD8−FoxP3RFP−CD25+GITR+ cells were 
FACS-sorted from Foxp3RFP (WT) and Foxp3RFPRelaf/f Relf/f thymii, treated with TAT-
CRE and cultured with IL-2 for 2 days before analysis. Graph shows the % of 
FoxP3+CD25+ Treg in gated live cells. (D–F) FACS analysis of lymphoid tissues of mice 
described in (A). (D) Representative FoxP3 expression in gated live TCR ?+CD4+CD8−. 
Numbers indicate the percentage in the gate. (E, F) Percentage (E) and absolute numbers of 
TCR ?+CD4+CD8− FoxP3+ Treg cells (F). (G) CD4+CD25−CD44low naïve T cells were 
sorted from the LN of indicated mice and stimulated with grading doses of hTGF ?. Graph 
shows the % of FoxP3+ among CD4+ cells after 4 days. In B, C, E and F, data is represented 
Oh et al. Page 24
Immunity. Author manuscript; available in PMC 2018 September 19.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
as mean +/− SEM of at least 3 experiments (n=4–10 mice/group). *p<0.05, **p<0.01, 
***p<0.001, n.s. non-significant. See also Figure S1.
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Figure 2. c-Rel is mainly dispensable for Treg homeostasis at steady-state
(A) Survival curves of WT (Foxp3YFP-creRel+/+) and Foxp3yfp-CRERelf/f littermates. (B) H/E 
staining of lung and liver sections from 6-week old mice. Bars=100μm; original 
magnification: 100X. (C–J) Lymphoid tissues of 6-week old mice were analyzed by flow 
cytometry. (C) Total cell count in spleen and LN. (D) Representative CD44 and CD62L 
expression in spleen T cells. (E–F)% and numbers of naïve (CD44lowCD62Lhi), TCM 
(CD44hiCD62Lhi) and TEM (CD44hiCD62Llow) in spleen T cells. (G) Representative 
IL-17A and IFN ? expression in spleen CD4+ T cells. Numbers indicate the % in quadrants 
(H) % and numbers of IFN ?+CD4+ T cells in spleen. (I) Representative FoxP3 expression in 
spleen CD4+ T cells. Numbers indicate the % in the gate. (J) Cumulative % and number of 
Treg cells in spleen. (K–L) in vivo colitis suppression assay. (K) Weight curves, shown as % 
of original weight. (L) Representative colon histology 6 weeks after transfer. Bars=100μm; 
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original magnification: 100X. In C and F–J, mean +/− SEM is shown. Data is representative 
or cumulative of 5 mice per group from two experiments. *p<0.05, **p<0.005. See also 
Figure S2.
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Figure 3. Mice lacking NF- ?B p65 in Treg cells develop lethal autoimmune syndrome
(A) Survival curves of WT (Foxp3YFP-creRela+/+) and Foxp3YFP-creRelaf/f littermates. (B) 
H/E staining of lung and liver sections from 4–6 week-old mice. Bars=100μm; original 
magnification: 100X. (C–I) Lymphoid tissues of 4–6 week-old mice were analyzed by flow 
cytometry. (C) Total cell count in spleen and LN. (D) Representative CD44 and CD62L 
expression in spleen T cells. (E–F)% and numbers of naïve (CD44lowCD62Lhi), TCM 
(CD44hiCD62Lhi) and TEM (CD44hiCD62Llow) in spleen T cells. (G) Representative 
IL-17A and IFN ? expression in spleen CD4+ T cells. Numbers indicate the % in quadrants 
(H) % and numbers of IFN ?+CD4+ T cells in spleen. (I) Representative FoxP3 expression in 
spleen CD4+ T cells. Numbers indicate the % in the gate. (J) Cumulative % and number of 
Treg cells in spleen. (K–L) in vivo colitis suppression assay. (K) Weight curves, shown as % 
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of original weight. (L) Representative colon histology 5 weeks after transfer. Bars=100μm; 
original magnification: 100X. In C and F–J, mean +/− SEM is shown. Data is representative 
or cumulative of 5 mice per group from 3 experiments. *p<0.05, **p<0.005. See also Figure 
S3.
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Figure 4. Complete ablation of the canonical NF- ?B pathway drives a Scurfy-like autoimmune 
syndrome
(A) Survival curves of WT (Foxp3YFP-creRela+/+Rel+/+) and Foxp3YFP-creRelaf/fRelf/f 
littermates. (B) H/E staining of lung and liver sections from 2–3-week old mice. 
Bars=100μm; original magnification: 100X. (C–I) Lymphoid tissues of 2–3 week-old mice 
were analyzed by flow cytometry. (C) Total cell count in spleen and LN. (D) Representative 
CD44 and CD62L expression in spleen T cells. (E–F)% and numbers of naïve 
(CD44lowCD62Lhi), TCM (CD44hiCD62Lhi) and TEM (CD44hiCD62Llow) in spleen T 
cells. (G) Representative IL-17A and IFN ? expression in spleen CD4+ T cells. Numbers 
indicate the % in quadrants. (H) % and numbers of IFN ?+CD4+ T cells in spleen. (I) 
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Representative FoxP3 expression in spleen CD4+ T cells. Numbers indicate the % in the 
gate. (J) Cumulative % and number of Treg cells in spleen. (K–L) in vivo colitis suppression 
assay. (K) Weight curves, shown as % of original weight. (L) Representative colon histology 
6 weeks after transfer. Bars=100μm; original magnification: 100X. In C and F–J, mean +/− 
SEM is shown. Data is representative or cumulative of 5 mice per group from two 
experiments. *p<0.05, **p<0.005. See also Figure S4.
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Figure 5. Tonic canonical NF- ?B signaling maintains Treg homeostasis and function in 
peripheral mature Treg cells
(A) Inducible deletion of Rela, Rel or both Rela and Rel in Treg cells was achieved by 
tamoxifen treatment of Foxp3eGFP-Cre-ERT2xRosa26stop-eYFP Relaf/f, Relf/f and Relaf/f Relf/f 
mice. YFP+ cells were gated from CD4+ cells and used for flow cytometry analysis. (B) 
Cumulative % of FoxP3+ Treg cells in total spleen CD4+ T cells. (C) YFP+ “recombined” 
Treg cells were sorted and stained for FoxP3, CD25 and GITR. A representative histogram 
is shown for each genotype. (D) Treg cells with inducible deletion of Rela and Rel after 
tamoxifen treatment were stimulated or not with anti-CD3 and anti-CD28 antibodies for 3 
hours. RNA was prepared from those Treg cells and the expression level of Foxp3 mRNA 
was examined by qPCR. The mean +/− S.D is shown. Data is representative of six mice per 
group from three experiments. (E–F) in vivo colitis suppression assay using sorted YFP+ 
recombined Treg cells. (E) Weight curves, shown as % of original weight. (F) Representative 
colon histology 5 weeks after transfer. Bars=100 μm; original magnification: 100X. In C and 
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F, mean +/− S.D is shown. Data is representative or cumulative of 5 mice per group from 3 
experiments. *p<0.05, **p<0.005.
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Figure 6. Canonical NF- ?B shapes the molecular identity of Treg cells
Treg and Tconv cells of the indicated genotypes were FACS-sorted, in vitro-activated or not 
for 3 hours and submitted to RNAseq. (A) Heatmap created by unsupervised hierarchical 
gene clustering shows normalized expression of transcripts whose expression was changed 
in at least 1 condition (FC>1, ANOVA p<0.05). (B) Log2 fold changes of Rela−/−Rel−/− Treg 
versus WT Treg and stimulated Rela−/−Rel−/− Treg versus stimulated WT Treg. 
Representative genes from down-regulated genes were indicated as blue and representative 
genes from upregulated genes were indicated as red. The size of the selected genes indicates 
p-values by ANOVA. (C) 5-way ANOVA analysis was performed to assess the association 
between genes and different factors (factor 1: Treg or Tconv; factor 2: stimulated or not; 
factor 3: Rela−/−Rel−/− or not; factor 4: Rela−/− or not; factor 5: Rel−/− or not). The Venn 
diagrams depict downregulated (top) and upregulated (bottom). (D) Representative genes 
from the genes with significantly changed expression in Rela−/−Rel−/− Treg cells were 
categorized by their function and the expression change was presented as heatmaps. (E) 
Representative flow cytometry plots from intracellular staining for IFN ? and IL-17 in CD4+ 
FoxP3+ Treg cells from Foxp3YFP-cre and Foxp3YFP-cre Relaf/fRelf/f. (F) Treg cells were 
isolated from Foxp3eGFP-Cre-ERT2xRosa26stope-YFP WT and 
Foxp3eGFP-Cre-ERT2xRosa26stop-eYFP Relaf/fRelf/f after tamoxifen treatment and expression 
of various genes were examined by qPCR. Log2 fold changes (Log2 FC) of gene expression 
in inducible DKO versus WT were shown. See also Figure S5.
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Figure 7. NF- ?B regulates the Treg-associated transcriptional program
(A–F) WT Tconv and Treg cells were isolated and stimulated or not for 3 hours. p65 ChIP 
was performed and subjected to library preparation and sequencing as described in the 
Methods section. (A) The Venn diagram represents the number of p65-binding peaks and 
overlapping and non-overlapping peaks between four groups. (B) Heatmap showing the 
distribution of mean log2 p65-ChIP/input signal for Treg stim/unstim (red) and Tconv stim/
unstim (blue) around peaks summits, +/− 5kb flanks from TSS, from each group: Treg-
specific (red bar), Treg-Tconv shared (green bar) and constitutive (purple bar). The log2 
p65-ChIP/input signal is also presented as histograms on the right. (C) Enrichment of motifs 
in Treg-specific peaks and Treg-Tconv shared peaks as determined by the SeqGL algorithm. 
(D) Comparison of quantile normalized, library-size normalized, DNase accessibility signals 
between Treg and Tconv around summits (+/−150bp) of three different peak sets. Mann-
Whitney U test P values comparing Treg vs. Tcon signal are also provided. (E) Comparison 
of ATAC-seq signals between Treg and Tconv of three different peak sets. (F) The log2 TPM 
counts for two sets of RNAseq data for Tconv, WT Treg and Rela−/−Rel−/− Treg (Right side 
columns of the heatmap) corresponding to Tconv signature and Treg signature genes were 
displayed as a heatmap. Genes with significant expression changes in Rela−/−Rel−/− vs WT 
Treg and Tconv vs Treg were indicated. Genes, within its −10kb to +5kb coordinates, 
associated with p65 constitutive peaks, Tconv-Treg shared peaks, Treg stim-specific peaks 
and FoxP3 peaks are also indicated along the leftside of the heatmap. The cluster heatmap 
shows the pairwise −log10 p-values for fisher exacts comparing the indicated annotation 
groups. (G) Example genes from the set of genes including p65 Treg stim-enriched peaks. 
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Tracks were created in WashU epigenome browser and display normalized p65, FoxP3, 
ATAC-seq and DNase HS sequencing signal. See also Figure S6.
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